This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Arsheeta Kumar, PharmD
Advertisement
Articles by Arsheeta Kumar, PharmD
Advertisement
Latest Updated Articles
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapePublished: April 17th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
2
A Common Virus May Hold New Clues to Lupus
3
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
